Ketorolac Trometamol Rompharm

Ketorolac Trometamol, the active ingredient in Ketorolac Trometamol Rompharm, is a nonsteroidal anti-inflammatory drug (NSAID) presented as an ophthalmic solution for ocular use. It is indicated for the treatment of postoperative ocular inflammation and ocular pain in patients following eye surgery.

GNH USA supplies Ketorolac Trometamol Rompharm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide. The product conforms to EU regulatory standards and is distributed through GNH USA's global network, ensuring quality and traceability.

Ketorolac Trometamol is an NSAID used in ophthalmology to control inflammation and pain after eye surgery.

- Postoperative ocular inflammation: reduces swelling and redness following ocular procedures. - Ocular pain: alleviates discomfort associated with surgical trauma. - Eye surgery recovery: improves patient comfort and visual recovery during the postoperative period.

Ketorolac Trometamol may cause local ocular reactions and, rarely, severe ocular complications.

Common Side Effects: - Burning or stinging sensation upon instillation. - Temporary eye redness. - Itching or mild irritation. - Increased tearing. - Blurred vision that resolves quickly. - Mild conjunctival hyperemia.

Serious or Rare Side Effects: - Corneal ulceration or epithelial defects. - Severe allergic reaction (e.g., angio‑edema, anaphylaxis). - Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Significant increase in intra‑ocular pressure. - Vision loss or persistent visual disturbances. - Endophthalmitis or serious ocular infection.

Ketorolac Trometamol should be used with caution and under professional supervision.

- Hypersensitivity: avoid in patients with known allergy to ketorolac or other NSAIDs. - Corneal disease: use cautiously in patients with compromised corneal integrity. - Active ocular infection: do not use until infection is resolved. - Concurrent topical NSAIDs: avoid combined use to reduce risk of toxicity. - Intra‑ocular pressure: monitor patients at risk for pressure elevation. - Store at room temperature: keep container tightly closed, protect from light and moisture.

Ketorolac Trometamol can interact with other medications, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid): - Systemic NSAIDs: concurrent use may increase systemic adverse effects. - Anticoagulants or antiplatelet agents: heightened risk of bleeding complications. - Other ocular anti‑inflammatory agents: additive toxicity may occur.

Moderate Interactions (Monitor Closely): - Corticosteroid eye drops: monitor for delayed wound healing. - Contact lens wear: may cause irritation; advise removal during treatment. - Ocular beta‑blockers: observe intra‑ocular pressure changes.